New aspects in the pathophysiology of preeclampsia.
暂无分享,去创建一个
J. Davison | F. Luft | S. Karumanchi | A. Jeyabalan | K. Conrad | R. Dechend | S. Quaggin | V. Homuth
[1] Lewis H Kuller,et al. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. , 2004, American journal of physiology. Heart and circulatory physiology.
[2] J. Granger,et al. L-Arginine Attenuates Hypertension in Pregnant Rats With Reduced Uterine Perfusion Pressure , 2004, Hypertension.
[3] G. Remuzzi,et al. l-Arginine Depletion in Preeclampsia Orients Nitric Oxide Synthase Toward Oxidant Species , 2004, Hypertension.
[4] K. Lim,et al. Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.
[5] Robert N. Taylor,et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. , 2004, The Journal of clinical endocrinology and metabolism.
[6] A. Jeyabalan,et al. Essential Role for Vascular Gelatinase Activity in Relaxin-Induced Renal Vasodilation, Hyperfiltration, and Reduced Myogenic Reactivity of Small Arteries , 2003, Circulation research.
[7] J. Foidart,et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. , 2003, The Journal of clinical endocrinology and metabolism.
[8] Seth M Steinberg,et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. , 2003, The New England journal of medicine.
[9] D. Saller,et al. Second‐Trimester Maternal Serum Placental Growth Factor and Vascular Endothelial Growth Factor for Predicting Severe, Early‐Onset Preeclampsia , 2003, Obstetrics and gynecology.
[10] A. Hingorani,et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia , 2003, The Lancet.
[11] S. Fisher,et al. The Human Placenta Remodels the Uterus by Using a Combination of Molecules That Govern Vasculogenesis or Leukocyte Extravasation , 2003, Annals of the New York Academy of Sciences.
[12] Y. Taketani,et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. , 2003, The Journal of clinical endocrinology and metabolism.
[13] G. Prescott,et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study , 2003, BMJ : British Medical Journal.
[14] Y. Matsui,et al. VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts. , 2003, Cardiovascular research.
[15] G. Wallukat,et al. AT1 Receptor Agonistic Antibodies From Preeclamptic Patients Stimulate NADPH Oxidase , 2003, Circulation.
[16] A. Luttun,et al. Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? , 2003, The Journal of clinical investigation.
[17] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .
[18] J. Haigh,et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. , 2003, The Journal of clinical investigation.
[19] K. Conrad,et al. Impaired Oxygen-dependent Reduction of HIF-1α and -2α Proteins in Pre-eclamptic Placentae , 2003 .
[20] Y. Pinto,et al. Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction. , 2003, Cardiovascular research.
[21] S. Bobst,et al. Maternal Autoantibodies From Preeclamptic Patients Active Angiotensin Receptors on Human Trophoblast Cells , 2003, The Journal of the Society for Gynecologic Investigation: JSGI.
[22] K. Conrad,et al. Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae. , 2003, Placenta.
[23] 清水 紀宏. VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts , 2003 .
[24] Robert N. Taylor,et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. , 2003, American journal of obstetrics and gynecology.
[25] F. Kabbinavar,et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Pouysségur,et al. Induction of Hypoxia-inducible Factor-1α by Transcriptional and Translational Mechanisms* , 2002, The Journal of Biological Chemistry.
[27] G. Wallukat,et al. Potential Role of Autoantibodies Belonging to the Immunoglobulin G-3 Subclass in Cardiac Dysfunction Among Patients With Dilated Cardiomyopathy , 2002, Circulation.
[28] H. Dvorak. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] K. Conrad,et al. Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[30] N. Sattar,et al. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? , 2002, BMJ : British Medical Journal.
[31] R. Schmieder,et al. Angiotensin Converting Enzyme Inhibition and Angiotensin II AT1-Receptor Blockade Reduce the Levels of Asymmetrical NG, NG-Dimethylarginine in Human Essential Hypertension* , 2002 .
[32] K. Alitalo,et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. , 2002, The American journal of pathology.
[33] A. Hsueh,et al. Activation of Orphan Receptors by the Hormone Relaxin , 2002, Science.
[34] R. T. Lie,et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. , 2001, BMJ : British Medical Journal.
[35] H. Lother,et al. Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness , 2001, Nature Medicine.
[36] D. Grobbee,et al. Excessive Urinary Albumin Levels Are Associated With Future Cardiovascular Mortality in Postmenopausal Women , 2001, Circulation.
[37] J. Pell,et al. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.
[38] K. Conrad,et al. Relaxin is essential for renal vasodilation during pregnancy in conscious rats. , 2001, The Journal of clinical investigation.
[39] C. Redman,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Expression of Inflammatory Cytokines in Placentas from Women with Preeclampsia* , 2022 .
[40] K. Conrad,et al. Endothelin and nitric oxide mediate reduced myogenic reactivity of small renal arteries from pregnant rats. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[41] D. Ganten,et al. Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. , 2000, Journal of the American Society of Nephrology : JASN.
[42] K. Conrad,et al. Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[43] G. Wallukat,et al. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension , 2000, Journal of hypertension.
[44] S. Gardiner,et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia , 2000, Nature.
[45] G. Wallukat,et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. , 2000, Circulation.
[46] M. Radomski,et al. Role of matrix metalloproteinase-2 in thrombin-induced vasorelaxation of rat mesenteric arteries. , 2000, American journal of physiology. Heart and circulatory physiology.
[47] K. Conrad,et al. Expression of endothelial nitric oxide synthase by extravillous trophoblast cells in the human placenta. , 2000, Placenta.
[48] M. Marrero,et al. Vascular Endothelial Growth Factor Signals Endothelial Cell Production of Nitric Oxide and Prostacyclin through Flk-1/KDR Activation of c-Src* , 1999, The Journal of Biological Chemistry.
[49] K. Conrad,et al. Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. , 1999, The American journal of physiology.
[50] K. Conrad,et al. Plasma and 24-h NOx and cGMP during normal pregnancy and preeclampsia in women on a reduced NOx diet. , 1999, American journal of physiology. Renal physiology.
[51] M. Post,et al. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. , 1999, The Journal of clinical investigation.
[52] M. Hod,et al. Microalbuminuria after pregnancy complicated by pre-eclampsia. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[53] D. Charnock-Jones,et al. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. , 1999, Molecular endocrinology.
[54] G. Wallukat,et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. , 1999, The Journal of clinical investigation.
[55] M. Goligorsky,et al. CO‐OPERATION BETWEEN ENDOTHELIN AND NITRIC OXIDE IN PROMOTING ENDOTHELIAL CELL MIGRATION AND ANGIOGENESIS , 1999, Clinical and experimental pharmacology & physiology.
[56] K. Conrad,et al. Relaxin is a potent renal vasodilator in conscious rats. , 1999, The Journal of clinical investigation.
[57] K. Conrad,et al. Circulating Levels of Immunoreactive Cytokines in Women with Preeclampsia , 1998, American journal of reproductive immunology.
[58] M. Drab,et al. Endothelial-cell permeability and protein kinase C in pre-eclampsia , 1998, The Lancet.
[59] M. Lindheimer,et al. Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. , 1998, The Journal of clinical investigation.
[60] F. Gejyo,et al. Postpartum renal lesions in women with pre-eclampsia. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[61] K. Lim,et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. , 1997, The American journal of pathology.
[62] C. Damsky,et al. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? , 1997, The Journal of clinical investigation.
[63] E. Dejana,et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? , 1997, The Journal of clinical investigation.
[64] A. Busjahn,et al. Endothelial adhesion molecules and leukocyte integrins in preeclamptic patients. , 1997, Hypertension.
[65] E. Amento,et al. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. , 1996, The Journal of clinical investigation.
[66] K. Conrad,et al. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. , 1995, The Journal of clinical investigation.
[67] A. Zanchetti,et al. Atrial natriuretic peptide and hemodynamic changes during normal human pregnancy. , 1995, Hypertension.
[68] R. Kendall,et al. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[69] L. Rochelle,et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] C. Damsky,et al. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. , 1993, The Journal of clinical investigation.
[71] T. Benedetti,et al. The Maternal Hemodynamic Effect of Indomethacin in Normal Pregnancy , 1992, Obstetrics and gynecology.
[72] K. Conrad,et al. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. , 1989, The American journal of physiology.
[73] L. Moore,et al. Blunted vasoreactivity in pregnant guinea pigs is not restored by meclofenamate. , 1989, American journal of obstetrics and gynecology.
[74] C. Baylis. Renal effects of cyclooxygenase inhibition in the pregnant rat. , 1987, The American journal of physiology.
[75] K. Conrad,et al. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. Serial studies in chronically instrumented, conscious rats. , 1986, The Journal of clinical investigation.
[76] E. Gallery,et al. Are the renal functional changes of human pregnancy caused by prostacyclin? , 1985, Prostaglandins.
[77] K. Conrad,et al. Renal hemodynamics during pregnancy in chronically catheterized, conscious rats. , 1984, Kidney international.
[78] R. Osathanondh,et al. Relaxin in Normal and Pathogenic Pregnancies , 1982, Obstetrics and gynecology.
[79] A. Donker,et al. Prostaglandin E2, plasma renin activity, and renal function throughout rabbit pregnancy. , 1982, The Journal of laboratory and clinical medicine.
[80] J. Elema,et al. MORPHOLOGICAL CHANGES OF THE SPIRAL ARTERIES IN THE PLACENTAE BED IN RELATION TO PRE‐ECLAMPSIA AND FETAL GROWTH RETARDATION , 1981, British journal of obstetrics and gynaecology.
[81] J. Tucci,et al. Urinary excretion of cyclic 3',5'-adenosine monophosphate and cyclic 3',5'-guanosine monophosphate during and after pregnancy. , 1977, The Journal of clinical endocrinology and metabolism.
[82] L. Chesley,et al. The remote prognosis of eclamptic women. , 1976, American heart journal.
[83] L. Chesley,et al. The remote prognosis of eclamptic women. Sixth periodic report. , 1976, American journal of obstetrics and gynecology.